ArticleDiabetes2015

Anti-CD3/Anti-CXCL10 Antibody Combination Therapy Induces a Persistent Remission of Type 1 Diabetes in Two Mouse Models.

Stanley Lasch et al.PubMed ↗Publisher ↗

No numbers read from the abstract.